ACADIA Pharmaceuticals
ACAD
#3888
Rank
NZ$6.08 B
Marketcap
NZ$35.55
Share price
0.58%
Change (1 day)
-2.58%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): NZ$0.21 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$1.13 Billion. In 2025 the company made an earning of NZ$0.24 Billion a decrease over its 2024 earnings that were of NZ$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.21 B-14.46%
2025 NZ$0.24 B-46.18%
2024 NZ$0.45 B-605.67%
2023 -NZ$90.71 Million-76.09%
2022 -NZ$0.38 Billion27.41%
2021 -NZ$0.3 Billion-40.38%
2020 -NZ$0.5 Billion19.88%
2019 -NZ$0.42 Billion-3.92%
2018 -NZ$0.44 Billion-15.04%
2017 -NZ$0.52 Billion6.33%
2016 -NZ$0.48 Billion64.55%
2015 -NZ$0.3 Billion77.47%
2014 -NZ$0.17 Billion143.69%
2013 -NZ$67.45 Million81.93%
2012 -NZ$37.08 Million-8.73%
2011 -NZ$40.62 Million-251.39%
2010 NZ$26.82 M-133.2%
2009 -NZ$80.82 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$87.19 Million36.99%
2005 -NZ$63.64 Million37.22%
2004 -NZ$46.38 Million19.96%
2003 -NZ$38.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.57 B 21,493.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.27 B 5,590.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.70 B 27,580.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.16 B 9,713.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-NZ$0.33 Billion-252.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-NZ$68.66 Million-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA